Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors

Blood

Volumn 89, Issue 5, 1997, Pages 1818-1823

  Petersdorf, Effie W ^a,b   Longton, Gary M ^a   Anasetti, Claudio ^a   Mickelson, Eric M ^a   McKinney, Susan K ^a   Smith, Anajane G ^a   Martin, Paul J ^a   Hansen, John A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN;

ALLELE; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; GRAFT FAILURE; GRAFT REJECTION; HISTOCOMPATIBILITY; HLA SYSTEM; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0031018433     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.5.1818.1818_1818_1823     Document Type: Article

References (46)

1. Geraghty DE: Structure of the HLA class I region and expression of its resident genes. Curr Opin Immunol 5:3, 1993
2. Thomas ED, Storb R, Clift RA, Feter A, Johnson L, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone marrow transplantation. N Engl J Med 292:895, 1975
3. Beatty PG, Clift RA, Mickelson EM, Nisperos BB, Flournoy N, Martin PJ, Sanders JE, Stewart P, Buckner CD, Storb R, Thomas ED, Hansen JA: Marrow transplantation from related donors other Than HLA-identical siblings. N Engl J Med 313:765, 1985
4. Sandberg L, Thorsby E, Kissmeyer-Nielsen F, Lindholm A: Evidence of a third sublocus within the HLA-A chromosomal region, in Terasaki PI (ed): Histocompatibility Testing. Copenhagen, Munksgaard, 1970, P 165
5. Grunnet N, Kristensen T, Kissmeyer-Nielsen F: Cell mediated lympholysis in man. The impact of HLA-C antigens. Tissue Antigens 7:301, 1976
6. Dill O, Kievits F, Koch S, Ivanyi P, Hammerling GJ: Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice. Proc Natl Acad Sci USA 85:5664, 1988
7. Kariyone AI, Tanabe M, Juji T, Kano K, Takiguchi M: Functional expression of HLA-C blank antigens on human blood lymphocytes. J Immunol 145:3714, 1990
8. Lanier LL, Gumperz JE, Parham P, Melero I, Lopez-Botet M, Phillips JH: The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 154:3320, 1995
9. Colonna M, Spies T, Strominger JL, Ciccone E, Moretta A, Moretta L, Pende D, Viale O: Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. Proc Natl Acad Sci USA 89;7983, 1992
10. Anasetti C, Amos D, Beatty PG, Appelbaum FR, Bensinger W, Buckner CD, Clift R, Doney K, Martin PJ, Mickelson E, Nisperos B, O'Quigley J, Ramberg R, Sanders JE, Stewart P, Storb R, Sullivan KM, Witherspoon RP, Thomas ED, Hansen JA: Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 320:197, 1989
11. O'Reilly RJ, Keever C, Kernan NA, Bordignon C, Flomenberg N: Graft host interactions following T-cell depleted marrow transplants, in Melchers F, Nicklin L (eds): Progress in Immunolog, vol 7. New York, NY, Springer-Verlag, 1989, p 1184
12. Ash RC, Casper JT, Chitambar CR, Hansen R, Bunin N, Truitt RL, Lawton C, Murray K, Hunter J, Baxter-Lowe LA, Gottschall JL, Oldham K, Anderson T, Camitta B, Menitove J: Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 322:485, 1990
13. Gale RP, Ho W, Feig S, Champlin R, Tesler A, Arenson E, Ladish S, Young L, Winston D, Sparkes R, Fitchen J, Territo M, Sarna G, Wong L, Paik Y, Bryson Y, Golde D, Fahey J, Cline M: Prevention of graft rejection following bone marrow transplantation. Blood 57:9, 1981
14. Beelen DW, Graeven U, Elmaagacli AH, Niederle N, Kloke O, Opalka B, Schaefer UW: Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome. Blood 85:2981, 1995
15. Champlin RE, Horowitz MM, van Bekkum DW, Camitta BM, Elfenbein GE, Gale RP, Gluckman E, Good RA, Rimm AA, Roxman C, Speck B, Bortin MM; Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 73:606, 1989
16. Storb R, Prentice RL, Thomas ED: Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296:61, 1977
17. Martin PJ, Hansen JA, Bucker CD, Sanders JE, Deeg HJ, Storb R, Thomas ED: Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts. Blood 66:664, 1985
18. Goldman JM, Apperley JF, Jones L, Marcus R, Goolden AW, Batchelor R, Hale G, Waldmann H, Reid CD, Hows J, Gordon-Smith E, Catovsky D, Galton DAG: Bone marrow transplantation for patients with chronic myeloid leukemia. N Engl J Med 314:202, 1986
19. Kernan NA, Bartsch G, Ash RC, Beatty PG, Champlin R, Filipovich A, Gajewski J, Hansen JA, Henslee-Downey J, McCullough J, McGlave P, Perkins HA, Phillips GL, Sanders J, Stroncek D, Thomas ED, Blume KG: Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 328:593, 1993
20. McGlave PB, Beatty P, Ash R, Hows JM: Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: Results in 102 cases. Blood 75:1728, 1990
21. Spencer A, Szydlo RM, Brookes PA, Kaminski E, Rule S, van Rhee F, Ward KN, Hale G, Waldmann H, Hows JM, Batchelor JR, Goldman JM: Bone marrow transplantation for chronic myeloid leukemia with volunteer unrelated donors using ex vivo or in vivo T-cell depletion: Major prognostic impact of HLA class I identity between donor and recipient. Blood 86:3590, 1995
22. Budowle B, Chakraborty R, Giusti AM, Eisenberg AJ, Allen RC: Analysis of the VNTR locus DIS80 by the PCR followed by high-resolution PAGE. Am J Hum Genet 48:137, 1991
23. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA: Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 85:1954, 1995
24. Durnam DM, Anders KR, Fisher L, O'Quigley J, Bryant EM, Thomas ED: Analysis of the origin of marrow cells in bone marrow transplant recipients using a Y-chromosome-specific in situ hybridization assay. Blood 74:2220, 1989
25. Petersdorf EW, Longton GM, Anasetti C, Martin PJ, Mickelson EM, Smith AG, Hansen JA: The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 86:1606, 1995
26. Petersdorf EW, Hansen JA: A comprehensive approach for typing the alleles of the HLA-B locus by automated sequencing. Tissue Antigens 46:73, 1995
27. Petersdorf EW, Stanley JF, Martin PJ, Hansen JA: Molecular diversity of the HLA-C locus in unrelated marrow transplantation. Tissue Antigens 44:93, 1994
28. Bodmer JG, Marsh SGE, Albert ED, Bodmer WF, Bontrop RE, Charron D, Dupont B, Erlich HA, Mach B, Mayr WR, Parham P, Sasazuki T, Schreuder GMTh, Strominger JL, Svejgaard A, Terasaki PI: Nomenclature for factors of the HLA system, 1995. Tissue Antigens 46:1, 1995
29. Bjorkman PJ, Saper MA, Samraoui B, Bennett WS, Strominger JL, Wiley DC: Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506, 1987
30. Browning MJ, Krausa P, Rowan A, Bicknell DC, Bodmer JG, Bodmer WF: Tissue typing the HLA-A locus from genomic DNA by sequence-specific PCR: Comparison of HLA genotype and surface expression on colorectal tumor cell lines. Proc Natl Acad Sci USA 90:2842, 1993
31. Smith AG, Mickelson EM, Marashi A, Petersdorf EW, Hansen JA: Heterogeneity within the HLA-B44 family of alleles: Implications for donor selection or unrelated marrow transplantation. Hum Immunol 40:26-C-6.2, 1994 (abstr) (suppl 1)
32. Bunce M, Welsh KI: Rapid DNA typing for HLA-C using sequence-specific primers (PCR-SSP): Identification of serological and non-serologically defined HLA-C alleles including several new alleles. Tissue Antigens 43:7, 1994
33. Breslow NE, Day NE: The analysis of case control studies, in Davis W (ed): Statistical Methods in Cancer Research, vol 1. Lyon, France, International Agency for Research on Cancer, 1980, p 248
34. Schlesselman JJ: Case-control studies. Design, conduct, analysis, in Monographs in Epidemiology and Biostatistics. New York, NY, Oxford, 1982
35. Fleischhauer K, Kernan NA, O'Reilly RJ, Dupont B, Yang SY: Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med 323:1818, 1990
36. Petersdorf EW, Smith AG, Mickelson E, Longton G, Anasetti C, Choo SY, Martin PJ, Hansen JA: The role of HLA-DPB1 disparity in the development of graft-versus-host disease following unrelated marrow transplantation. Blood 81:1923, 1993
37. Hellstrom KE, Hellstrom I, Bergheden C: Allogeneic inhibition of tumor cells by in vitro contact with cells containing foreign H-2 antigens. Nature (London) 208:458, 1965
38. Snell GD: Recognition structures determined by the H-2 complex. Transplant Proc 8:147, 1976
39. Dennert G, Anderson CG, Warner J: T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance. J Immunol 135:3729, 1985
40. Strom TB, Tilney NL, Carpenter CB, Busch GJ: Identity and cytotoxic capacity of cells infiltrating renal allografts. N Engl J Med: 292:1257, 1975
41. Snell GD: Histocompatibility genes of the mouse. II. Production and analysis of isogenic resistant lines. J Natl Cancer lnst 21:843, 1958
42. Cudkowicz G, Bennett M: Peculiar immunobiology of bone marrow allografts II. Rejection of parental grafts by resistant F1 hybrid mice. J Exp Med 134:1513, 1971
43. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G: Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts. Eur J Immunol 7:655, 1977
44. Storkus WJ, Howell DN, Salter RD, Dawson JR, Cresswell P: NK susceptibility varies inversely with target cell class I HLA antigen expression. J Immunol 138:1657, 1987
45. Glas R, Sturmhofel K, Hammerling GJ, Karre K, Ljunggren H-G: Restoration of a tumorigenic phenotype by β2-microglobulin transfection to EL-4 mutant cells. J Exp Med 175:843, 1992
46. Litwin V, Gumperz J, Parham P, Phillips JH, Lanier LL: Specificity of HLA class I antigen recognition by human NK clones: Evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type. J Exp Med 178:1321, 1993